CLINICAL_TRIALS
trial_result
· 2024-12-16
Clinical Trial Update: Concentration-QT Study of Paroxetine in Healthy Adults [Phase 1]
Summary
Results from a Phase 1 concentration-QT study of paroxetine in healthy adults have been completed, with cardiac safety results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Anxiety Disorders | Phase 1 | Status: COMPLETED | Results posted: 2024-12-16